Page last updated: 2024-11-05

trientine and Diabetic Cardiomyopathies

trientine has been researched along with Diabetic Cardiomyopathies in 1 studies

Trientine: An ethylenediamine derivative used as stabilizer for EPOXY RESINS, as ampholyte for ISOELECTRIC FOCUSING and as chelating agent for copper in HEPATOLENTICULAR DEGENERATION.
TETA : An azamacrocyle in which four nitrogen atoms at positions 1, 4, 8 and 11 of a fouteen-membered ring are each substituted with a carboxymethyl group.
2,2,2-tetramine : A polyazaalkane that is decane in which the carbon atoms at positions 1, 4, 7 and 10 are replaced by nitrogens.

Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, L1
Ward, ML1
Phillips, AR1
Zhang, S1
Kennedy, J1
Barry, B1
Cannell, MB1
Cooper, GJ1

Other Studies

1 other study available for trientine and Diabetic Cardiomyopathies

ArticleYear
Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats.
    Cardiovascular diabetology, 2013, Aug-28, Volume: 12

    Topics: Animals; Calcium; Cardiotonic Agents; Chelating Agents; Copper; Diabetes Mellitus, Experimental; Dia

2013